Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
397 people get Q articles and Market Currents by email alert.
Get email alerts on Q »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
There are no Transcripts on Q.
-
at CNBC.com (May 30, 2013)
-
at CNBC.com (May 14, 2013)
-
at CNBC.com (May 13, 2013)
-
at CNBC.com (May 9, 2013)
-
at CNBC.com (May 9, 2013)
Q vs. ETF Alternatives
Company Description
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 9, 7:39 PM Quintiles (Q) finshed its IPO debut today in the green, with the company’s shares ending the day at $42.11, up more than 5% from their initial offering price of $40. The company provides testing and diagnostic services to biopharmaceutical companies, and could see a boon to business with the implementation of President Obama’s health-care overhaul. Comment! [Healthcare, On the Move]
LATEST REPLIES